Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129251) titled 'Tocilizumab for the Treatment of Active Adult-Onset Still's Disease: A Multicenter, Randomized Controlled Clinical Trial on Efficacy and Safety' on Aug. 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Condition:
Adult-onset Still's disease
Intervention:
Intervention group(TCZ + csDMARD + hormone group):Tocilizumab Injection
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-30
Target Sample Size: Intervention group(TCZ + csDMARD + hormone group):52;Control group (place...